However, when combined with GLP-1 activity, the glucagon effects shift toward thermogenesis and fat oxidation rather than hyperglycemia
Refer to the charts above
Those with a BMI of 35 or over may be eligible for bariatric surgery covered by Medicare
Unlock in-depth information about this drug - its R&D Status, Core Patent, Clinical Trials, and Global Approval Status
This information, combined with your clinical history, biomarker trends (HbA1c, lipid panel, GLP-1 levels where available), and tolerability profile, creates a more complete picture supporting shared decision-making about whether transitioning to compounded tirzepatide serves your long-term metabolic goals
What you eat matters more on this medication than it ever did before, because the delayed gastric emptying amplifies the effects of every dietary choice